Trial Profile
A 12 Week, Multi-Centre, Open Label Study To Evaluate The Efficacy, Tolerability And Safety Of A Fesoterodine Flexible Dose Regimen In Patients With Overactive Bladder.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Mar 2012
Price :
$35
*
At a glance
- Drugs Fesoterodine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms SAFINA
- 27 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Feb 2010 Actual patient number (331) added as reported by ClinicalTrials.gov.
- 27 Feb 2010 Actual end date (January 2010) added as reported by ClinicalTrials.gov.